Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Jan Hendrik Hooijberg(Vrije Universiteit Amsterdam), Gerrit Jansen(Amsterdam UMC Location VUmc), Paul Noordhuis(Vrije Universiteit Amsterdam), Godefridus J. Peters(Gdańsk Medical University), Piet Borst(The Netherlands Cancer Institute), Marcel Kool(German Cancer Research Center), Herbert M. Pinedo(Leiden University), Henk J. Broxterman(Vrije Universiteit Amsterdam), Rik J. Scheper(Unknown), Yehuda G. Assaraf(Technion – Israel Institute of Technology)
PubMed
June 1, 1999
Cited by 445
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691